ライフサイエンスコーパス: wound complication

1 sociated with an increased risk of abdominal wound complication.

2 , effective, and decreases hospital stay and wound complications.

3 echnical considerations designed to minimize wound complications.

4 have favored submuscular insertion to avoid wound complications.

5 etic patients despite higher risk of sternal wound complications.

6 sidered in patients at high risk for sternal wound complications.

7 included surgical-site infections and other wound complications.

8 dectomy, parathyroid autotransplantation, or wound complications.

9 atients were recruited; 16 (13.7%) developed wound complications.

10 therapies, and their effect on perioperative wound complications.

11 ed factors that might predispose patients to wound complications.

12 return to full activity and fewer long-term wound complications.

13 6 months in mean WBC, HgB, or platelets, or wound complications.

14 ses were performed to identify predictors of wound complications.

15 creases the incidence of ischemic events and wound complications.

16 urgical dissection required often results in wound complications.

17 al disability and increase the likelihood of wound complications.

18 as been anecdotally associated with surgical wound complications.

19 n technical losses or in posttransplantation wound complications.

20 remity tumors were associated with increased wound complications.

21 omplications were wound infections and other wound complications.

22 primary nonfunction, 3% vs. 2% (P=0.38); and wound complications, 19% vs. 17% (P=0.54).

23 patients who underwent MIG experienced less wound complications (2% vs 5%, P = 0.006).

24 ow-up of 22.1 (range, 7.67-41.11) months, 29 wound complications (2.53%) had occurred [bleeding 0%/in

25 (7.8% vs. 19.6%, P=0.007), and nonoperative wound complications (2.9% vs. 14.2%, P=0.001).

26 aravalvular leak, 2 patients (11%) had groin wound complications, 2 patients (11%) required a permane

27 1.7%; RR mortality = 2.9; 95% CI = 2.3-3.7), wound complications (21.1%; RR mortality = 0.7; 95% CI =

28 Most common readmission reasons were wound complications (30.7%), gastrointestinal (16.1%), b

29 5%, P = 0.26) rates favored LC with perineal wound complications (38.3% vs 50.0%, P = 0.26) in favor

30 rgical site infection (3.2% vs 3.2%, P=.91), wound complication (5.9% vs 6.5%, P=.30), any complicati

31 occurred in 215 (35.0%) patients, including: wound complications (61, 9.9%), chest infection (50, 8.1

32 eduction (group 2 vs. group 1) in cumulative wound complications (7.8% vs. 19.6%, P=0.007), and nonop

33 ded hypertension (12% v 1.8%, respectively), wound complications (abdominal incisional hernia or infu

34 that is widely used to reduce postoperative wound complications after coronary-artery bypass graftin

35 Postoperative wound complications after excisional surgery for primary

36 Wound complications after IR were associated with signif

37 Outcome measures included wound complication and hernia recurrence.

38 With the exception of superficial wound complications and atrial dysrhythmias, obesity is

39 BMP-2 was associated with increased risk for wound complications and dysphagia.

40 idity and mortality comparable with OG, less wound complications and shorter hospitalization.

41 Secondary outcome measures included wound complications and the composite of death, myocardi

42 Secondary outcome measures included wound complications and the composite of death, myocardi

43 were detected between patients who developed wound complications and those who did not.

44 d 2.5- to 4.5-fold higher risk of developing wound complications, and a 4-to 8-fold higher risk of de

45 for uterine infection, obstetrical surgical wound complications, and cardiopulmonary and thromboembo

46 y profiles (hospital readmission, infection, wound complications, and metabolic complications).

47 myocardial infarction, dialysis requirement, wound complications, and need for surgical reinterventio

48 postpartum hemorrhage, obstetrical surgical wound complications, and pelvic injury.

49 ncluded demographics, perioperative details, wound complications, and recurrences.

50 The true incidence of postoperative wound complications, and their correlation with closure

51 eloped fistula; nine patients, perioperative wound complications; and four patients, pelvic infection

52 ates of superficial surgical site infection, wound complication, any complication, and 30-day mortali

53 Our hypothesis was that wound complications are related, in part, to the immune

54 in the number of minor, major, or infectious wound complications between the groups.

55 nt characteristics have been associated with wound complications, but there is currently no quantitat

56 deep infection/abscess by 37%, and for minor wound complications by 54%.

57 Twenty-four wound complications developed in 18 (46.2%) patients, in

58 mine the incidence of, and risk factors for, wound complications (e.g., infections, hernias) in kidne

59 Perineal wound complications frequently occur after eAPR with pre

60 toperative complications: general morbidity, wound complications, general infections, pulmonary compl

61 bowel habits or malabsorption; only 1 minor wound complication has occurred.

62 atic colorectal cancer (CRC), an increase in wound complications has been observed in patients who un

63 We studied postoperative surgical wound complications in 15 kidney recipients receiving si

64 Predictors of wound complications included ASA score, diabetes, smokin

65 rimary advantage is an extremely low risk of wound complications, including infection and hernia.

66 or subtotal thyroidectomy (p = 0.001) while wound complications increased after radical neck dissect

67 transumbilical SIL surgery, the incidence of wound complications is acceptable low and is further red

68 es, the significantly increased incidence of wound complications leads to the conclusion that ELAPE s

69 e 4 thrombocytopenia and limited increase in wound complications may be observed.

70 gical site infection (SSI) and noninfectious wound complications (NIWCs) after delayed (DR) and secon

71 ld provide a practical predictive marker for wound complications on which selective antibiotic prophy

72 Patients were classified as having a wound complication or not.

73 s developed postoperative bowel obstruction, wound complications, or anastomotic leaks or died.

74 rol group experienced more than one surgical wound complication (P=0.014), and the relaparotomy incid

75 s a significant and independent predictor of wound complications (P < 0.005 and P < 0.0001,respective

76 The incidence of wound complications, pain, recurrences, and patients dis

77 postoperative morbidity, general infections, wound complications, pulmonary complications, prolonged

78 Likewise, there was no difference in wound complication rate between patients with SDD and th

79 d decreasing the target sirolimus level, the wound complication rate in the sirolimus group was 35% (

80 In the first phase of the study, the wound complication rate in the sirolimus group was 55% (

81 series have raised concerns toward a higher wound complication rate related to the transumbilical in

82 demonstrated a significantly higher surgical wound complication rate, but graft and patient survival

83 ed follow-up, albeit at the cost of a higher wound complication rate.

84 characteristics were associated with higher wound complication rates: diabetes (P = 0.02); larger tu

85 sting was associated with lower harvest site wound complications relative to open vein-graft harvesti

86 sting was associated with lower harvest site wound complications relative to open vein-graft harvesti

87 e mofetil who were pair-matched for surgical wound complication risk factors.

88 l infections (RR = 1.73; 95% CI: 1.32-2.28), wound complications (RR = 1.23; 95% CI: 1.09-1.40), pulm

89 eral morbidity (RR=1.52, 95% CI: 1.33-1.74), wound complications (RR=2.15, 95% CI: 1.87-2.49), genera

90 A laparoscopic approach results in fewer wound complications than an open approach.

91 The rate of sternal wound complication was 3.5% in the bilateral-graft group

92 Although wound complication was the most common reason for readmi

93 Superficial wound complication was the most common wound event, 2.24

94 The incidence of wound complications was 10% and 2 patients required a se

95 x on hematologic grade 3 or 4 toxicities and wound complications was analyzed.

96 The only significant predictors of a wound complication were morbid obesity (BMI >30), having

97 Surgical wound complications were defined as any complication rel

98 Wound complications were defined as drainage, erythema,

99 stic regression models for the prediction of wound complications were developed.

100 Wound complications were diagnosed within the first 2 po

101 Postoperative wound complications were identified in 61 (47.7%) patien

102 Wound complications were observed in 13.5% of patients:

103 r a minimum of 6 months postoperatively, and wound complications were recorded as bleeding, infection

104 More wound complications were seen in prepatients (25.9% vs 1

105 ease in 30-day hospital readmission rates or wound complications when compared with discharge 1 or 2

106 There were more sternal wound complications with bilateral internal-thoracic-art

107 but a significantly lower incidence of total wound complications with intradermal suture closure than

108 g bivariate relationships with postoperative wound complications with P < or = 0.20 were submitted fo

109 f graciloplasty patients experienced a major wound complication, with therapy failing in 41%.